Validea's guru fundamental report indicates that AMGEN INC (AMGN) receives a rating of 80% based on Meb Faber's Shareholder Yield Investor model, which favors companies returning cash to shareholders through dividends, buybacks, and debt paydown. While AMGN scores well on net payout yield, quality and debt, and relative strength, it fails on valuation and shareholder yield criteria within the model. The report suggests the stock has some interest based on the strategy, but not strong interest.
AMGEN INC (AMGN), a large-cap growth stock within the Biotechnology & Drugs sector, has received an 80% rating from Validea's fundamental report based on Meb Faber's Shareholder Yield Investor model. This model specifically targets companies that prioritize returning cash to shareholders through dividends, share buybacks, and debt reduction. An 80% score signifies some level of interest from this strategy, falling short of the 90% threshold for strong interest. The analysis indicates AMGN successfully meets the criteria for Net Payout Yield, Quality and Debt, and Relative Strength. However, the company did not pass the model's tests for Valuation and, notably, for the specific 'Shareholder Yield' metric itself, despite the overarching strategy's focus on this aspect. This mixed performance across the model's criteria contributes to the moderately positive sentiment observed for AMGN in this context.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
